Sanofi, OpenAI
Sanofi partners with OpenAI: here’s how it will mitigate AI related risks
Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development. What’s in it for Sanofi? Working with the AI company will help Sanofi “go to market faster with our drugs” and address the unmet patient needs,
Sanofi Partners With OpenAI, Formation Bio on AI-Driven Drug Development
French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence.
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings.
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data,
France's Sanofi Partners With OpenAI to Accelerate Drug Development
By Mauro Orru French pharmaceutical company Sanofi is partnering with Sam Altman's OpenAI and AI pharma company Formation Bio to expedite the development
Sanofi, OpenAI To Build AI Software To Boost Drug Development
French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Sanofi SNY announced that it has entered into a first-in-class artificial intelligence (AI) collaboration with Formation Bio and OpenAI to build AI-powered software to expedite the development of drugs.
STAT13d
Lilly doubles down on radiopharma
Aktis Oncology said today that it's struck an agreement with Eli Lilly to discover new radiopharmaceuticals. This comes after ...
devdiscourse12d
Latest Health Developments: From Bird Flu to Revolutionary AI Drug Projects
Recent health news highlights FDA bird flu testing in milk, Sanofi's AI-driven drug development partnership, and GSK's promising asthma drug. Also noted are Eli Lilly’s diabetes drug approval in China ...
Exscientia: Drug Discovery Platform Attracting Partners And Cash
Exscientia uses AI to accelerate drug development and reduce time to market, potentially improving success rates. Read why ...